SH3PXD2A and neoplasm: This decrease in tumor growth was also observed with the D7 Tks5 KD cells (p<0.0001 by two-way repeated ANOVA with Bonferroni post-hoc test) (Fig 2E), suggesting that the Tks5 effect on tumor growth is not due to off-target effects of the shRNA.